Day: September 3, 2025

Third $100M share repurchase authorization announced since November 2023 PALO ALTO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Upwork Inc. (Nasdaq: UPWK), the world’s human and AI-powered work marketplace, today announced that its board of directors approved an additional $100 million share repurchase program. “Upwork’s financial results continue to exceed expectations, giving us another opportunity to utilize our balance sheet to increase shareholder value,” said Hayden Brown, president and CEO, Upwork. “Our track record of operational discipline and rapid execution is enabling us to grow GSV and continue our market share gains.” Repurchases of Upwork’s common stock under the repurchase authorization may be made from time to time on the open market (including through the use of trading plans intended to qualify under Rule 10b5-1...

SOUTH SAN FRANCISCO, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will present at an upcoming healthcare investor conference. H.C. Wainwright 27th Annual Global Investment Conference on Wednesday, September 10, 2025 Surrozen presentation will be from 8:30 – 9:00 AM Pacific Time/11:30 –12N Eastern Time Interested parties may access the audio webcast for the conference via the Investors section of the Surrozen website at https://investors.surrozen.com/events-presentations/events-calendar. A replay of the webcast will be archived on the website at www.surrozen.com. About Surrozen  Surrozen is a biotechnology...

WARREN, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today highlighted the continuing need for SARS-CoV-2 treatments for individuals with weakened immune systems, who are at the highest risk of complications from the virus. TVGN 489, the Company’s investigational allogeneic SARS-CoV-2-specific Cytotoxic CD8+ T lymphocyte (CTL) immunotherapy is developed using the ExacTcell platform. It is designed to fortify anti-SARS-CoV-2 immunity in these individuals and directly eliminate the virus. The CTLs are directed against the entire viral genome rather than single protein. Publication of positive POC/dose finding clinical trial data of TVGN 489 is available through Blood Advances: Clinical Trial Key Findings:The treatment arm, which included high-risk patients and half of...

Ra’anana, Israel, Sept. 03, 2025 (GLOBE NEWSWIRE) — Rail Vision Ltd. (Nasdaq: RVSN), an early commercialization stage technology company seeking to revolutionize railway safety and the data-related market, today announced that it has received a notification letter from Nasdaq Stock Market LLC (“Nasdaq”) that the Company has been granted an additional 180-day compliance period, or until March 2, 2026 to regain compliance with Nasdaq’s minimum bid price rule. Nasdaq’s determination is based on the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market, with the exception of the bid price requirement, and the Company’s written notice of its intention to cure the deficiency during the second compliance period and...

HIGHLIGHTSA maiden reverse circulation (RC) drilling program is underway at Sherlock Crossing in the West Pilbara, testing high-grade Au-Sb mineralisation at the historic Clarke Mine. The drill program consists of 8 holes on 4 sections for ~1,000 m RC over a strike length of 300 m. Drilling aims to define down dip continuity of high-grade veins mapped at surface, to extend mineralisation to the north and south and to potentially define plunge of the mineralising system. RC drilling is anticipated to be completed in September with results expected in mid-October 2025. At the Wyloo Project in the South Pilbara, mapping and sampling confirmed coherent Sb-Ag-Au anomalism in readiness for drilling. Peak results from rock chip sampling of the polymetallic vein-style mineralisation include 482 g/t Ag, 1.29% Sb, 0.93 g/t Au, 2.6% Cu, 9.7% Pb...

New global clinical insights initiative debuts at World Sleep Congress 2025 to help drive innovation in sleep health care SAN DIEGO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced the launch of Sleep Institute, a global clinical insights initiative dedicated to advancing the science and understanding of sleep health. Sleep Institute partners with clinicians, researchers, policymakers, and health system leaders to deliver objective, non-commercial, evidence-based insights that help inform care innovation, support policy decisions, and elevate sleep as a global health priority. The announcement comes ahead of the World Sleep Congress, taking place September 5–10 in Singapore. Sleep disorders are among...

Dallas, Texas, Sept. 03, 2025 (GLOBE NEWSWIRE) — Kronos Worldwide, Inc. (NYSE: KRO) (the “Company”) announced today that its wholly-owned subsidiary, Kronos International, Inc. (“KII”), has agreed to sell €75 million aggregate principal amount of additional 9.50% Senior Secured Notes due 2029 (the “Notes”) through an institutional private placement. The Notes will be issued as additional notes to the existing €351,174,000 aggregate principal amount of 9.50% Senior Secured Notes due 2029 that KII issued on February 12, 2024 and July 30, 2024 (the “Existing Notes”). Other than with respect to the date of issuance and issue price, the Notes will have the same terms as the Existing Notes. The Notes will be maintained under the same ISIN and Common Code numbers as the Existing Notes, except that the Notes issued pursuant to Regulation...

HAMILTON, Bermuda, Sept. 03, 2025 (GLOBE NEWSWIRE) — SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE: SPNT), a global specialty insurer and reinsurer, has today announced the appointment of Martin Hudson as Board Director, effective September 1, 2025. Mr. Hudson has more than 40 years of international (re)insurance leadership experience, spanning underwriting, risk management, governance, and executive management. Since 2015, he has served as an Independent Non-Executive Director and Chair of the Board across a number of companies, including SiriusPoint International Insurance Corporation (publ). He is also currently Independent Non-Executive Director at Liberty Mutual Managing Agency Ltd and Liberty Mutual Insurance Europe SE. Mr. Hudson has also served on the boards of Apollo Syndicate Management Ltd, MS Amlin Underwriting...

NEW YORK, Sept. 03, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for August 2025 on its Investor Relations website. A data sheet showing this information can be found at: http://ir.nasdaq.com/financials/volume-statistics. About NasdaqNasdaq (Nasdaq: NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the...

HOUSTON, TX, Sept. 03, 2025 (GLOBE NEWSWIRE) — Pyrophyte Acquisition Corp. II (Nasdaq: PAII.U) (the “Company”) announced that holders of the units sold in the Company’s initial public offering of 20,041,150 units, which includes 2,541,150 units issued pursuant to the partial exercise by the underwriters of their overallotment option, completed on July 24, 2025 (the “Offering”), may elect to separately trade the Class A ordinary shares and warrants included in the units commencing on or about September 8, 2025. Any units not separated will continue to trade on the New York Stock Exchange under the symbol “PAII.U,” and each of the Class A ordinary shares and warrants will separately trade on the New York Stock Exchange under the symbols “PAII” and “PAII WS,” respectively. No fractional warrants will be issued upon separation of...